Crossmark

Inflammation-induced hypoparathyroidism triggered by combination immune checkpoint blockade for melanoma

Crossref DOI link: https://doi.org/10.1186/s40425-019-0528-x

Published Online: 2019-02-21

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Trinh, Beckey

Sanchez, Guacimara Ortega

Herzig, Petra

Läubli, Heinz https://orcid.org/0000-0002-8910-5620
Funding

Funding for this research was provided by:

Goldschmidt-Jacobson (na)
More Information

Article History

Received: 19 December 2018

Accepted: 6 February 2019

First Online: 21 February 2019

Ethics approval and consent to participate

: Ethics approval was obtained from the local ethical committee to analyze the tissue and blood samples. Written informed consent was obtained from the patients for the analysis of the samples.

: A consent for publication was obtained from the patient. A copy of the written consent is available for review.

: H.L received travel grants and consultant fees from Bristol-Myers Squibb (BMS), Roche and Merck, Sharp and Dohme (MSD).

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.